What is it about?
The use of a biologic agent to avoid recurrences of allergic fungal sinusitis after endoscopic sinus surgery. The gold standard is the daily use of an intranasal steroid, but in this study we found out that a single subcutaneous injection of omalizumab is as effective and can prevent recurrences for up to 6 months without side effects.
Featured Image
Read the Original
This page is a summary of: Omalizumab versus intranasal steroids in the post-operative management of patients with allergic fungal rhinosinusitis, European Archives of Oto-Rhino-Laryngology, September 2019, Springer Science + Business Media,
DOI: 10.1007/s00405-019-05650-y.
You can read the full text:
Contributors
The following have contributed to this page
